Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.

Harris AH, Oliva E, Bowe T, Humphreys KN, Kivlahan DR, Trafton JA.

Psychiatr Serv. 2012 Jul;63(7):679-85. doi: 10.1176/appi.ps.201000553.

PMID:
22549276
2.

Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration.

Del Re AC, Gordon AJ, Lembke A, Harris AH.

Addict Sci Clin Pract. 2013 Jul 8;8:12. doi: 10.1186/1940-0640-8-12.

3.

Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.

Harris AH, Ellerbe L, Reeder RN, Bowe T, Gordon AJ, Hagedorn H, Oliva E, Lembke A, Kivlahan D, Trafton JA.

Psychol Serv. 2013 Nov;10(4):410-9. doi: 10.1037/a0030949. Epub 2013 Jan 28.

PMID:
23356858
4.

Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.

Harris AH, Kivlahan DR, Bowe T, Humphreys KN.

Psychiatr Serv. 2010 Apr;61(4):392-8. doi: 10.1176/ps.2010.61.4.392.

PMID:
20360279
5.

Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.

Baser O, Chalk M, Rawson R, Gastfriend DR.

Am J Manag Care. 2011 Jun;17 Suppl 8:S222-34.

PMID:
21761948
6.

Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.

Abrams TE, Lund BC, Bernardy NC, Friedman MJ.

Psychiatr Serv. 2013 Feb 1;64(2):142-8. doi: 10.1176/appi.ps.201200217.

PMID:
23474508
7.

Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.

Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH.

J Psychiatr Res. 2015 Oct;69:150-7. doi: 10.1016/j.jpsychires.2015.07.016. Epub 2015 Jul 22.

PMID:
26343607
8.

Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness.

Harris AH, Bowe T, Hagedorn H, Nevedal A, Finlay AK, Gidwani R, Rosen C, Kay C, Christopher M.

Addict Sci Clin Pract. 2016 Sep 15;11(1):15. doi: 10.1186/s13722-016-0063-8.

9.

Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study.

Iheanacho T, Issa M, Marienfeld C, Rosenheck R.

Drug Alcohol Depend. 2013 Sep 1;132(1-2):122-6. doi: 10.1016/j.drugalcdep.2013.01.016. Epub 2013 Feb 22.

PMID:
23434041
10.

Veterans' Service Utilization Patterns After Alcohol and Opioid Detoxification in VHA Care.

Timko C, Gupta S, Schultz N, Harris AH.

Psychiatr Serv. 2016 Apr 1;67(4):460-4. doi: 10.1176/appi.ps.201400579. Epub 2016 Jan 14.

PMID:
26766752
11.

Long-acting injectable depot naltrexone use in the Veterans' Health Administration: a national study.

Marienfeld C, Iheanacho T, Issa M, Rosenheck RA.

Addict Behav. 2014 Feb;39(2):434-8. doi: 10.1016/j.addbeh.2013.05.006. Epub 2013 May 21.

PMID:
23790742
12.

Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors.

Oliva EM, Harris AH, Trafton JA, Gordon AJ.

Drug Alcohol Depend. 2012 May 1;122(3):241-6. doi: 10.1016/j.drugalcdep.2011.10.004. Epub 2011 Nov 23.

PMID:
22115887
13.

Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption.

Robinson S, Bowe T, Harris AH.

J Subst Abuse Treat. 2013 Nov-Dec;45(5):475-7. doi: 10.1016/j.jsat.2013.06.009. Epub 2013 Aug 9.

14.

Pharmacotherapy of alcohol use disorders: seventy-five years of progress.

Zindel LR, Kranzler HR.

J Stud Alcohol Drugs Suppl. 2014;75 Suppl 17:79-88. Review.

15.

Extended release naltrexone for alcohol use disorders: quasi-experimental effects on mortality and subsequent detoxification episodes.

Harris AH, Bowe T, Del Re AC, Finlay AK, Oliva E, Myrick HL, Rubinsky AD.

Alcohol Clin Exp Res. 2015 Jan;39(1):79-83. doi: 10.1111/acer.12597.

PMID:
25623408
16.

Patient and facility characteristics associated with benzodiazepine prescribing for veterans with PTSD.

Lund BC, Bernardy NC, Vaughan-Sarrazin M, Alexander B, Friedman MJ.

Psychiatr Serv. 2013 Feb 1;64(2):149-55. doi: 10.1176/appi.ps.201200267.

PMID:
23154834
18.

Medicaid coverage of medications to treat alcohol and opioid dependence.

Mark TL, Lubran R, McCance-Katz EF, Chalk M, Richardson J.

J Subst Abuse Treat. 2015 Aug;55:1-5. doi: 10.1016/j.jsat.2015.04.009. Epub 2015 Apr 16.

PMID:
25921475
19.

Sex differences in chronic pain management practices for patients receiving opioids from the Veterans Health Administration.

Oliva EM, Midboe AM, Lewis ET, Henderson PT, Dalton AL, Im JJ, Seal K, Paik MC, Trafton JA.

Pain Med. 2015 Jan;16(1):112-8. doi: 10.1111/pme.12501. Epub 2014 Jul 13.

PMID:
25039721
20.

Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.

Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I.

Drug Alcohol Depend. 2016 Mar 1;160:222-6. doi: 10.1016/j.drugalcdep.2016.01.013. Epub 2016 Jan 24.

Supplemental Content

Support Center